CNS & Neurological Disorders - Drug Targets
aims to cover all the latest and outstanding developments
on the medicinal chemistry, pharmacology, molecular biology,
genomics and biochemistry of contemporary molecular targets
involved in neurological and central nervous system (CNS)
disorders e.g. disease specific proteins, receptors, enzymes,
genes.
CNS & Neurological Disorders - Drug Targets
publishes guest edited thematic issues written by leaders
in the field covering a range of current topics of CNS &
neurological drug targets. The journal also accepts for
publication original research articles, letters, reviews
and drug clinical trial studies.
As the discovery, identification, characterization and validation
of novel human drug targets for neurological and CNS drug
discovery continues to grow; this journal is essential reading
for all pharmaceutical scientists involved in drug discovery
and development.
